Molecular epidemiology of DNA repair and cancer susceptibility- a review of population-based studies

DNA Repair, Genetic Instability, and Cancer

Volumn , Issue , 2007, Pages 315-344

  Hu, Zhibin ^a   Wang, Li E ^b   Wei, Qingyi ^b  

^a The University of Texas M D Anderson Cancer Center ^*

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84967373582     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812706782_0012     Document Type: Chapter

References (115)

1. Sancar A. (1995) DNArepair in humans. Annu Rev Genet 29: 69-105.
2. Wood RD, MitchellM, Sgouros J, LindahlT. (2001)HumanDNArepair genes. Science 291: 1284-1289.
3. PeroRW, Bryngelsson C, Mitelman F, et al. (1978) Inter-individual variation in the responses of cultured human lymphocytes to exposure from DNA damaging chemical agents: inter-individual variation to carcinogen exposure. Mutat Res 53: 327-341.
4. Friedberg EC,Walker GC, SiedeW. (1995) DNArepair and mutagenesis. ASM Press, Washington (DC).
5. Wei Q. (1998) Effect of aging on DNArepair and skin carcinogenesis: a mini-review of population-based studies. J Investig Dermatol Symp Proc 3: 19-22.
6. Neumann AS, Sturgis EM, Wei Q. (2005) Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers: a review of molecular epidemiological studies. Mol Carcinog 42: 65-92.
7. Qiao Y, Spitz MR, Guo Z, et al. (2002) Rapid assessment of repair of ultraviolet DNAdamage with a modified host-cell reactivation assay using a luciferase reporter gene and correlation with polymorphisms of DNA repair genes in normal human lymphocytes. Mutat Res 509: 165-174.
8. Spitz MR, Wei Q, Dong Q, et al. (2003) Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev 12: 689-698.
9. Athas WF, Hedayati MA, Matanoski GM, et al. (1991) Development and field-test validation of an assay for DNA repair in circulating human lymphocytes. Cancer Res 51: 5786-5793.
10. Wei Q,Matanoski GM, Farmer ER, et al. (1993) DNArepair and aging in basal cell carcinoma: a molecular epidemiology study. Proc Natl Acad Sci USA 90: 1614-1618.
11. Protic-Sabljic M, Kraemer KH. (1985) One pyrimidine dimer inactivates expression of a transfected gene in xeroderma pigmentosum cells. Proc Natl Acad Sci USA 82: 6622-6626.
12. Hall J, English DR,Artuso M, et al. (1994)DNArepair capacity as a risk factor for non-melanocytic skin cancer-a molecular epidemiological study. Int J Cancer 58: 179-184.
13. D’Errico M, CalcagnileA, Iavarone I, et al. (1999) Factors that influence the DNA repair capacity of normal and skin cancer-affected individuals. Cancer Epidemiol Biomarkers Prev 8: 553-559.
14. Matta JL, Villa JL, Ramos JM, et al. (2003) DNA repair and nonmelanoma skin cancer in Puerto Rican populations. J Am Acad Dermatol 49: 433-439.
15. LandiMT, Baccarelli A, Tarone RE, et al. (2002)DNArepair, dysplastic nevi, and sunlight sensitivity in the development of cutaneous malignant melanoma. J Natl Cancer Inst 94: 94-101.
16. WeiQ, Lee JE, Gershenwald JE, et al. (2003) Repair ofUVlight-induced DNAdamage and risk of cutaneous malignant melanoma. J Natl Cancer Inst 95: 308-315.
17. WeiQ, Cheng L, Hong WK, et al. (1996) ReducedDNArepair capacity in lung cancer patients. Cancer Res 56: 4103-4107.
18. Wei Q, Cheng L, Amos CI, et al. (2000) Repair of tobacco carcinogeninduced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 92: 1764-1772.
19. Shen H, Spitz MR, Qiao Y, et al. (2003) Smoking, DNArepair capacity and risk of non-small cell lung cancer. Int J Cancer 107: 84-88.
20. Cheng L, Eicher SA, Guo Z, et al. (1998) ReducedDNArepair capacity in and neck cancer patients. Cancer Epidemiol Biomarkers Prev 7: 465-468.
21. Hu JJ, HallMC, Grossman L, et al. (2004) Deficient nucleotide excision repair capacity enhances human prostate cancer risk. Cancer Res 64: 1197-1201.
22. Shi Q, Wang LE, Bondy ML, et al. (2004) Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. Carcinogenesis 25: 1695-1700.
23. Ahn B, Kang D, KimH, et al. (2004) Repair of mitomycin C crosslinked DNA in mammalian cells measured by a host cell reactivation assay. Mol Cells 18: 249-255.
24. Everson RB, Randerath E, Santella RM, et al. (1986) Detection of smoking-related covalent DNA adducts in human placenta. Science 231: 54-57.
25. Geneste O, Camus AM, Castegnaro M, et al. (1991) Comparison of pulmonary DNA adduct levels, measured by 32P-postlabelling and aryl hydrocarbon hydroxylase activity in lung parenchyma of smokers and ex-smokers. Carcinogenesis 12: 1301-1305.
26. Li D, Wang M, Cheng L, et al. (1996) In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer. Cancer Res 56: 3638-3641.
27. Phillips DH. (2002) Smoking-related DNA and protein adducts in human tissues. Carcinogenesis 23: 1979-2004.
28. Phillips DH, Hemminki K, Alhonen A, et al. (1988) Monitoring occupational exposure to carcinogens: detection by 32P-postlabelling of aromatic DNAadducts in white blood cells from iron foundry workers. Mutat Res 204: 531-541.
29. Phillips DH, Schoket B, Hewer A, et al. (1990) Influence of cigarette smoking on the levels ofDNAadducts inhumanbronchial epithelium and white blood cells. Int J Cancer 46: 569-575.
30. Palli D, Vineis P, Russo A, et al. (2000) Diet, metabolic polymorphisms and dna adducts: the EPIC-Italy cross-sectional study. Int J Cancer 87: 444-451.
31. Peluso M, Airoldi L, Magagnotti C, et al. (2000) White blood cell DNA adducts and fruit and vegetable consumption in bladder cancer. Carcinogenesis 21: 183-187.
32. Hu JJ, Roush GC, Berwick M, et al. (1996) Effects of dietary supplementation of alpha-tocopherol on plasma glutathione andDNArepair activities. Cancer Epidemiol Biomarkers Prev 5: 263-270.
33. Veglia F, Matullo G, Vineis P. (2003) Bulky DNA adducts and risk of cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 12: 157-160.
34. Kennedy DO, Agrawal M, Shen J, et al. (2005) DNArepair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer. J Natl Cancer Inst 97: 127-132
35. Wei Q, Xu X, Cheng L, et al. (1995) Simultaneous amplification of four DNArepair genes and beta-actin in human lymphocytes by multiplex reverse transcriptase-PCR. Cancer Res 55: 5025-5029.
36. WeiQ, GuanY, Cheng L, et al. (1997) Expression of five selectedhuman mismatch repair genes simultaneously detected in normal and cancer cell lines by a non-radioactive multiplex reverse transcriptionpolymerase chain reaction. Pathobiology 65: 293-300.
37. Cheng L, Guan Y, Li L, et al. (1999) Expression in normal human tissues of five nucleotide excision repair genes measured simultaneously by multiplex reverse transcription-polymerase chain reaction. Cancer Epidemiol Biomarkers Prev 8: 801-807.
38. Cheng L, Spitz MR, Hong WK, et al. (2000) Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis. Carcinogenesis 21: 1527-1530.
39. Cheng L, Sturgis EM, Eicher SA, et al. (2002) Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck. Cancer 94: 393-397.
40. Wei Q, Wang LE, Sturgis EM, et al. (2005) Expression of nucleotide excision repair proteins in lymphocytes as a marker of susceptibility to squamous cell carcinomas of the head and neck. Cancer Epidemiol Biomarkers Prev 14: 1961-1966.
41. Kruglyak L, Nickerson DA. (2001) Variation is the spice of life. Nat Genet 27: 234-236.
42. Risch N, Merikangas K. (1996) The future of genetic studies of complex human diseases. Science 273: 1516-1517.
43. Lander ES. (1996) The new genomics: global views of biology. Science 274: 536-539.
44. Lichtenstein P, Holm NV, Verkasalo PK, et al. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343: 78-85.
45. Anglian Breast Cancer Study Group. (2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 83: 1301-1308.
46. Pharoah PD, Antoniou A, Bobrow M, et al. (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31: 33-36.
47. Lander ES, Schork NJ. (1994) Genetic dissection of complex traits. Science 265: 2037-2048.
48. Risch NJ. (2000) Searching for genetic determinants in the new millennium. Nature 405: 847-856.
49. Peltonen L, McKusick VA. (2001) Genomics and medicine. Dissecting human disease in the postgenomic era. Science 291: 1224-1229.
50. Daly MJ, Rioux JD, Schaffner SF, et al. (2001) High-resolution haplotype structure in the human genome. Nat Genet 29: 229-232.
51. Patil N, Berno AJ, Hinds DA, et al. (2001) Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 294: 1719-1723.
52. Gabriel SB, Schaffner SF, Nguyen H, et al. (2002) The structure of haplotype blocks in the human genome. Science 296: 2225-2229.
53. Altshuler D, Brooks LD, Chakravarti A, et al. (2005)Ahaplotype map of the human genome. Nature 437: 1299-1320.
54. Neale BM, Sham PC. (2004) The future of association studies: genebased analysis and replication. Am J Hum Genet 75: 353-362.
55. Rebbeck TR, Spitz M, Wu X. (2004) Assessing the function of genetic variants in candidate gene association studies. Nat Rev Genet 5: 589-597.
56. BotsteinD, Risch N. (2003) Discovering genotypes underlying human phenotypes: past successes for Mendelian disease, future approaches for complex disease. Nat Genet 33(Suppl): 228-237.
57. Ng PC, Henikoff S. (2001) Predicting deleterious amino acid substitutions. Genome Res 11: 863-874.
58. Ramensky V, Bork P, Sunyaev S. (2002) Human non-synonymous SNPs: server and survey. Nucl Acids Res 30: 3894-3900.
59. ZhuY, Spitz MR,AmosCI, et al. (2004)Anevolutionary perspective on single-nucleotide polymorphism screening in molecular cancer epidemiology. Cancer Res 64: 2251-2257.
60. Sanyal S, Festa F, Sakano S, et al. (2004) Polymorphisms inDNArepair and metabolic genes in bladder cancer. Carcinogenesis 25: 729-734.
61. Jeon HS, Kim KM, Park SH, et al. (2003) Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer. Carcinogenesis 24: 1677-1681.
62. Yamamoto H, Hanafusa H, Ouchida M, et al. (2005) Single nucleotide polymorphisms in the EXO1 gene and risk of colorectal cancer in a Japanese population. Carcinogenesis 26: 411-416.
63. Hu Z, Ma H, Chen F, et al. (2005) XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev 14: 1810-1818.
64. Pritchard JK, Cox NJ. (2002) The allelic architecture of human disease genes: common disease-common variant or not? Hum Mol Genet 11: 2417-2423.
65. Blangero J. (2004) Localization and identification of human quantitative trait loci: king harvest has surely come. Curr Opin Genet Dev 14: 233-240.
66. WeissKM, ClarkAG. (2002) Linkage disequilibrium and the mapping of complex human traits. Trends Genet 18: 19-24.
67. Smith DJ, Lusis AJ. (2002) The allelic structure of common disease. Hum Mol Genet 11: 2455-2461.
68. Wang WY, Pike N. (2004) The allelic spectra of common diseases may resemble the allelic spectrum of the full genome. Med Hypotheses 63: 748-751.
69. Frank SA. (2004) Genetic predisposition to cancer - insights from population genetics. Nat Rev Genet 5: 764-772.
70. Shiloh Y. (1997) Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu Rev Genet 31: 635-662.
71. Savitsky K, Bar-Shira A, Gilad S, et al. (1995)Asingle ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749-1753.
72. Angele S, Romestaing P, MoullanN, et al. (2003)ATMhaplotypes and cellular response to DNAdamage: association with breast cancer risk and clinical radiosensitivity. Cancer Res 63: 8717-8725.
73. Lee KM, Choi JY, Park SK, et al. (2005) Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14: 821-825.
74. Tamimi RM, Hankinson SE, Spiegelman D, et al. (2004) Common ataxia telangiectasia mutated haplotypes and risk of breast cancer: a nested case-control study. Breast Cancer Res 6: R416-R422.
75. Masson M, Niedergang C, Schreiber V, et al. (1998) XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol 18: 3563-3571.
76. Fan J, Otterlei M,Wong HK, et al. (2004) XRCC1 co-localizes and physically interacts with PCNA. Nucleic Acids Res 32: 2193-2201.
77. LunnRM,Langlois RG, Hsieh LL, et al. (1999)XRCC1polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 59: 2557-2561.
78. Duell EJ, Wiencke JK, Cheng TJ, et al. (2000) Polymorphisms in the DNArepair genes XRCC1 and ERCC2 and biomarkers of DNAdamage in human blood mononuclear cells. Carcinogenesis 21: 965-971.
79. Matullo G, Guarrera S, Carturan S, et al. (2001)DNArepair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer 92: 562-567.
80. Lei YC, Hwang SJ, Chang CC, et al. (2002) Effects on sister chromatid exchange frequency of polymorphisms in DNA repair gene XRCC1 in smokers. Mutat Res 519: 93-101.
81. Hsieh LL, Chien HT, Chen IH, et al. (2003) The XRCC1 399Gln polymorphism and the frequency of p53 mutations inTaiwanese oral squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 12: 439-443.
82. Hu JJ, Smith TR, MillerMS, et al. (2001) Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis 22: 917-922.
83. Taylor RM, Thistlethwaite A, Caldecott KW. (2002) Central role for the XRCC1 BRCT I domain in mammalian DNA single-strand break repair. Mol Cell Biol 22: 2556-2563.
84. Pastorelli R, CerriA, Mezzetti M, et al. (2002) Effect ofDNArepair gene polymorphisms on BPDE-DNA adducts in human lymphocytes. Int J Cancer 100: 9-13.
85. Gao WM, Romkes M, Day RD, et al. (2003) Association of the DNA repair gene XPDAsp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer. Carcinogenesis 24: 1671-1676.
86. Hou SM, Ryk C, KannioA, et al. (2003) Influence of common XPD and XRCC1 variant alleles on p53 mutations in lung tumors. Environ Mol Mutagen 41: 37-42.
87. Wang Y, Spitz MR, Zhu Y, et al. (2003) From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair 2: 901-908.
88. Huang WY, Olshan AF, Schwartz SM, et al. (2005) Selected genetic polymorphisms inMGMT, XRCC1, XPD, and XRCC3 and risk of head and neck cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev 14: 1747-1753.
89. Coin F,Marinoni JC, Rodolfo C, et al. (1998) Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH. Nat Genet 20: 184-188.
90. Winkler GS, Araujo SJ, Fiedler U, et al. (2000) TFIIH with inactive XPD helicase functions in transcription initiation but is defective in DNA repair. J Biol Chem 275: 4258-4266.
91. Shen MR, Jones IM,Mohrenweiser H. (1998) Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 58: 604-608.
92. Lunn RM, Helzlsouer KJ, Parshad R, et al. (2000)XPDpolymorphisms: effects on DNArepair proficiency. Carcinogenesis 21: 551-555.
93. Moller P, Knudsen LE, Frentz G, et al. (1998) Seasonal variation of DNAdamage and repair in patients with non-melanoma skin cancer and referents with and without psoriasis. Mutat Res 407: 25-34.
94. Goode EL, UlrichCM,Potter JD. (2002) Polymorphisms inDNArepair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11: 1513-1530.
95. Hu Z, Wei Q, Wang X, et al. (2004) DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis. Lung Cancer 46: 1-10.
96. Benhamou S, Sarasin A. (2005) ERCC2 /XPD gene polymorphisms and lung cancer: a HuGE review. Am J Epidemiol 161: 1-14.
97. Han J, Colditz GA, Liu JS, et al. (2005) Genetic variation in XPD, sun exposure, and risk of skin cancer. Cancer Epidemiol Biomarkers Prev 14: 1539-1544.
98. Tebbs RS, Zhao Y, Tucker JD, et al. (1995) Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNArepair gene. Proc Natl Acad Sci USA 92: 6354-6358.
99. Liu N, Lamerdin JE, Tebbs RS, et al. (1998) XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA crosslinks and other damages. Mol Cell 1: 783-793.
100. Masson JY, Stasiak AZ, Stasiak A, et al. (2001) Complex formation by the human RAD51C and XRCC3 recombination repair proteins. Proc Natl Acad Sci USA 98: 8440-8446.
101. Winsey SL, Haldar NA, Marsh HP, et al. (2000) A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res 60: 5612-5616.
102. Kuschel B,AuranenA, McBride S, et al. (2002)Variants inDNAdoublestrand break repair genes and breast cancer susceptibility. Hum Mol Genet 11: 1399-1407.
103. Auranen A, Song H,Waterfall C, et al. (2005) Polymorphisms in DNA repair genes and epithelial ovarian cancer risk. Int J Cancer 117: 611-618.
104. Webb PM, Hopper JL, Newman B, et al. (2005) Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer. Cancer Epidemiol Biomarkers Prev 14: 319-323.
105. Tranah GJ, Giovannucci E, Ma J, et al. (2004) XRCC2 and XRCC3 polymorphisms are not associated with risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev 13: 1090-1091.
106. Han J, Hankinson SE, Ranu H, et al. (2004) Polymorphisms in DNA double-strand break repair genes and breast cancer risk in the Nurses’ Health Study. Carcinogenesis 25: 189-195.
107. Ioannidis JP, Ntzani EE, Trikalinos TA, et al. (2001) Replication validity of genetic association studies. Nat Genet 29: 306-309.
108. Hirschhorn JN, DalyMJ. (2005) Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6: 95-108.
109. Newton-Cheh C, Hirschhorn JN. (2005) Genetic association studies of complex traits: design and analysis issues. Mutat Res 573: 54-69.
110. Doerge RW, Churchill GA. (1996) Permutation tests for multiple loci affecting a quantitative character. Genetics 142: 285-294.
111. Storey JD,Tibshirani R. (2003) Statistical significance for genome-wide studies. Proc Natl Acad Sci USA 100: 9440-9445.
112. Pritchard JK, Rosenberg NA. (1999) Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 65: 220-228.
113. Bacanu SA, Devlin B, Roeder K. (2000) The power of genomic control. Am J Hum Genet 66: 1933-1944.
114. Jorde LB. (2000) Linkage disequilibrium and the search for complex disease genes. Genome Res 10: 1435-1444.
115. Mayo M. (2005) Learning Petri net models of non-linear gene interactions. Biosystems 82: 74-82.